<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="4-part\PMC7302680\results\search\disease\results.xml">
  <result pre="Abstract Abstract To observe the efficacy of telbivudine in chronic" exact="hepatitis" post="B (CHB) women with high viral load during pregnancy"/>
  <result pre="to principle of informed consent. All infants received injection of" exact="hepatitis" post="B immune globulin (HBIG; 200 IU) and were vaccinated"/>
  <result pre="efficacy and safety mother-neonatal transmission pregnancy telbivudine 1 Introduction Chronic" exact="hepatitis" post="B virus (CHB) infection remains to be a global"/>
  <result pre="a major contributor to HBV epidemics.[6,7] The combination of both" exact="hepatitis" post="B immunoglobulin (HBIg) and HBV vaccine in newborn was"/>
  <result pre="patients had HBV DNA levels great than 107 IU/mL. Coinfection with" exact="hepatitis" post="C virus, hepatitis D virus, hepatitis A virus, hepatitis"/>
  <result pre="DNA levels great than 107 IU/mL. Coinfection with hepatitis C virus," exact="hepatitis" post="D virus, hepatitis A virus, hepatitis E virus, human"/>
  <result pre="than 107 IU/mL. Coinfection with hepatitis C virus, hepatitis D virus," exact="hepatitis" post="A virus, hepatitis E virus, human immunodeficiency virus, concurrently"/>
  <result pre="with hepatitis C virus, hepatitis D virus, hepatitis A virus," exact="hepatitis" post="E virus, human immunodeficiency virus, concurrently being confirmed with"/>
  <result pre="being confirmed with other liver diseases (drug-induced hepatitis, nonalcoholic steatohepatitis," exact="autoimmune hepatitis," post="ntrahepatic cholestasis of pregnancy, etc.) or having signs of"/>
  <result pre="other liver diseases (drug-induced hepatitis, nonalcoholic steatohepatitis, autoimmune hepatitis, ntrahepatic" exact="cholestasis" post="of pregnancy, etc.) or having signs of fetal dysplasia"/>
  <result pre="hao, lin zhou. Abbreviations: ADV = adefovir, CHB = chronic" exact="hepatitis" post="B, CI = confidence interval, ETV = entecavir, HBsAg"/>
  <result pre="B, CI = confidence interval, ETV = entecavir, HBsAg =" exact="hepatitis" post="B surface antigen, HBV DNA = hepatitis B virus"/>
  <result pre="entecavir, HBsAg = hepatitis B surface antigen, HBV DNA =" exact="hepatitis" post="B virus deoxyribonucleic acid, LAM = lamivudine, PCR ="/>
  <result pre="al.Effect of nucleos(t)ide analogue on serum HBsAg level in chronic" exact="hepatitis" post="B patients: a 3-years study. Biomed Pharmacother2020;122:109698.31918272 [2]ZhengCYanHZengJet al.Comparison"/>
  <result pre="pegylated interferon plus tenofovir combination therapy in patients with chronic" exact="hepatitis" post="B. Infect Drug Resist2019;12:845–54.31114265 [3]SarinSKKumarMLauGKet al.Asian-Pacific clinical practice guidelines"/>
  <result pre="Resist2019;12:845–54.31114265 [3]SarinSKKumarMLauGKet al.Asian-Pacific clinical practice guidelines on the management of" exact="hepatitis" post="B: a 2015 update. Hepatol Int2016;10:1–98. [4]collab: European Association"/>
  <result pre="Liver. EASL 2017 Clinical Practice Guidelines on the management of" exact="hepatitis" post="B virus infection. J Hepatol2017;67:370–98.28427875 [5]AnaedobeCGFowotadeAOmoruyiCEet al.Prevalence, sociodemographic features"/>
  <result pre="Med J2015;20:406.26301010 [6]GoyalAMurrayJMThe impact of vaccination and antiviral therapy on" exact="hepatitis" post="B and hepatitis D epidemiology. PLos One2014;9:e110143.25313681 [7]YiWLiMHXieYet al.Prospective"/>
  <result pre="impact of vaccination and antiviral therapy on hepatitis B and" exact="hepatitis" post="D epidemiology. PLos One2014;9:e110143.25313681 [7]YiWLiMHXieYet al.Prospective cohort study on"/>
  <result pre="of telbivudine used throughout pregnancy in blocking mother-to-child transmission of" exact="hepatitis" post="B virus. J Viral Hepat2017;24: suppl 1: 49–56.29082650 [8]LiJChangMSTranTTet"/>
  <result pre="infected mothers-Guam, 2014. J Pediatric Infect Dis Soc2018;7:290–5.28992071 [10]LimSSLiaoHTTsaiCYTelbivudine associated" exact="mitochondrial myopathy." post="Liver Int2018;38:1139.29570939 [11]ZhangHPanCQPangQet al.Telbivudine or lamivudine use in late"/>
  <result pre="lamivudine use in late pregnancy safely reduces perinatal transmission of" exact="hepatitis" post="B virus in real-life practice. Hepatology2014;60:468–76.25187919 [12]HuYXuCXuBet al.Safety and"/>
  <result pre="of telbivudine in late pregnancy to prevent mother-to-child transmission of" exact="hepatitis" post="B virus: a multicenter prospective cohort study. J Viral"/>
  <result pre="telbivudine in pregnancy for the prevention of perinatal transmission of" exact="hepatitis" post="B virus infection. J Hepatol2011;55:1215–21.21703206 [16]HanGRJiangHXYueXet al.Efficacy and safety"/>
  <result pre="in pregnant women for the prevention of perinatal transmission of" exact="hepatitis" post="B virus infection. J Viral Hepat2015;22:754–62.25641421 [17]WuQHuangHSunXet al.Telbivudine prevents"/>
  <result pre="infection. J Viral Hepat2015;22:754–62.25641421 [17]WuQHuangHSunXet al.Telbivudine prevents vertical transmission of" exact="hepatitis" post="B virus from women with high viral loads: a"/>
  <result pre="prospective long-term study. Clin Gastroenterol Hepatol2015;13:1170–6.25251571 [18]TanZYinYZhouJet al.Telbivudine treatment of" exact="hepatitis" post="B virus-infected pregnant women at different gestational stages for"/>
  <result pre="treatment during pregnancy. Medicine (Baltimore)2016;95:e4847.27749537 [19]BrownRJMcMahonBJLokASet al.Antiviral therapy in chronic" exact="hepatitis" post="B viral infection during pregnancy: a systematic review and"/>
 </snippets>
</snippetsTree>
